Fritextsökning
Innehållstyper
-
Nya blodtrycksgener identifierade
Åtta hittills okända gener som påverkar blodtrycket har kartlagts i en stor internationell studie.
-
Framåt för kombinationer mot hepatit C
Medivir går in i fas II samtidigt som konkurrenten Gileads kombinationsbehandling mot hepatit C får godkänt av FDA.
-
EMA bjuder in patienter
Pilotprojekt utvärderar hur patienter kan bidra till CHMP:s beslutsprocess.
-
Biotage i patenttvist om labbutrustning
Det svenska bolaget Biotage har fått en stämningsansökan emot sig i USA. -Motparten saknar fog för påståendet, säger Biotages vd Torben Jørgensen.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Tigran får fransk order
Genom partnerbolaget Advanced Medical Products har Tigran tagit i sin hittills största order sedan försäljningsstarten ifjol.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Instrument för skräddarsydd behandling snart här
En apparat stor som en mobiltelefon kan komma att revolutionera förskrivningen av läkemedel.
-
50 får gå från Pfizer - vd slutar
Pfizers vd Niklas Prager lämnar bolaget i samband med en omorganisation som träder i kraft i april.
-
Autoklaverbara provrörsställ lämpliga för låga temperaturer
Ordning. De nya provrörsställen Cryoelite Benchmate är tillverkade i polypropylen och kan enkelt rengöras i diskmaskin eller autoklaveras.
-
Per Norstedt, Regional Manager, AH Diagnostics
Why are you going to Scanlab+Biotech Forum?
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Positivt besked för Selincro
Lundbecks läkemedel för att minska alkoholkonsumtionen hos personer som dricker för mycket, rekommenderas av CHMP.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Refrigerators and freezers with small footprints
The Biocompact series of freezers and refrigerators from Gram Commercial offers a small yet professional footprint.
-
Nio nya antikroppar relaterade till jonkanaler
Novus Biologicals lanserar nio antikroppar för djupare studium av jonkanalers funktion.
BREAKING